Unlocking the secrets of the immune system.
Head of Research, Dr Helen Rippon, explains why research is critical to developing our understanding of immunotherapy.
Find Out More
Targeting triple-negative breast cancer
March 20, 2015
Around 15 to 20 per cent of breast cancer patients will have triple-negative breast cancer. It’s harder to treat and fewer therapies are available, but with his latest grant Professor Miguel del Pozo in Madrid is trying to change this.
A new cancer vaccine?
March 16, 2015
We’ve just awarded funding to Dr Kristen Radford and her team at the University of Queensland to develop a new type of ‘cancer vaccine’, based on a special type of white blood cell.